- Home
- PROK vs MVBF Comparison
PROK vs MVBF Comparison
Compare PROK & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PROK | MVBF |
|---|---|---|
| Founded | 2015 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 331.2M | 329.1M |
| IPO Year | 2021 | 2004 |
Fundamental Metrics
Financial Performance| Metric | PROK | MVBF |
|---|---|---|
| Price | $2.23 | $25.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $7.40 | ★ $27.60 |
| AVG Volume (30 Days) | ★ 493.9K | 27.6K |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | N/A | ★ 2.69% |
| EPS Growth | N/A | ★ 34.64 |
| EPS | N/A | ★ 2.06 |
| Revenue | $76,000.00 | ★ $3,400,000.00 |
| Revenue This Year | $1,010.19 | $1.28 |
| Revenue Next Year | N/A | $13.59 |
| P/E Ratio | ★ N/A | $14.62 |
| Revenue Growth | N/A | ★ 51.92 |
| 52 Week Low | $0.46 | $15.59 |
| 52 Week High | $7.13 | $29.59 |
Technical Indicators
Market Signals| Indicator | PROK | MVBF |
|---|---|---|
| Relative Strength Index (RSI) | 48.91 | 32.64 |
| Support Level | $2.09 | $22.50 |
| Resistance Level | $2.58 | $27.15 |
| Average True Range (ATR) | 0.16 | 0.76 |
| MACD | 0.00 | -0.22 |
| Stochastic Oscillator | 16.28 | 12.11 |
Price Performance
Historical ComparisonAbout PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.